Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

MAST3: a novel IBD risk factor that modulates TLR4 signaling.

Labbé C, Goyette P, Lefebvre C, Stevens C, Green T, Tello-Ruiz MK, Cao Z, Landry AL, Stempak J, Annese V, Latiano A, Brant SR, Duerr RH, Taylor KD, Cho JH, Steinhart AH, Daly MJ, Silverberg MS, Xavier RJ, Rioux JD.

Genes Immun. 2008 Oct;9(7):602-12. doi: 10.1038/gene.2008.57.

2.

Genome-wide expression profiling implicates a MAST3-regulated gene set in colonic mucosal inflammation of ulcerative colitis patients.

Labbé C, Boucher G, Foisy S, Alikashani A, Nkwimi H, David G, Beaudoin M, Goyette P, Charron G, Xavier RJ, Rioux JD.

Inflamm Bowel Dis. 2012 Jun;18(6):1072-80. doi: 10.1002/ibd.21887.

3.

Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogs.

Kathrani A, House A, Catchpole B, Murphy A, German A, Werling D, Allenspach K.

PLoS One. 2010 Dec 23;5(12):e15740. doi: 10.1371/journal.pone.0015740.

4.

Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.

Mokry M, Middendorp S, Wiegerinck CL, Witte M, Teunissen H, Meddens CA, Cuppen E, Clevers H, Nieuwenhuis EE.

Gastroenterology. 2014 Apr;146(4):1040-7. doi: 10.1053/j.gastro.2013.12.003.

PMID:
24333384
5.

Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.

Wei SC, Rosenberg IM, Cao Z, Huett AS, Xavier RJ, Podolsky DK.

Inflamm Bowel Dis. 2012 May;18(5):877-88. doi: 10.1002/ibd.22883.

6.

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases.

De Jager PL, Franchimont D, Waliszewska A, Bitton A, Cohen A, Langelier D, Belaiche J, Vermeire S, Farwell L, Goris A, Libioulle C, Jani N, Dassopoulos T, Bromfield GP, Dubois B, Cho JH, Brant SR, Duerr RH, Yang H, Rotter JI, Silverberg MS, Steinhart AH, Daly MJ, Podolsky DK, Louis E, Hafler DA, Rioux JD; Quebec IBD Genetics Consortium.; NIDDK IBD Genetics Consortium..

Genes Immun. 2007 Jul;8(5):387-97.

PMID:
17538633
7.

Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways.

Han YW, Choi JY, Uyangaa E, Kim SB, Kim JH, Kim BS, Kim K, Eo SK.

PLoS Pathog. 2014 Sep 4;10(9):e1004319. doi: 10.1371/journal.ppat.1004319.

8.
10.

Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients.

Berkowitz D, Peri R, Lavy A, Kessel A.

Hum Immunol. 2013 Dec;74(12):1519-23. doi: 10.1016/j.humimm.2013.08.285.

PMID:
24007656
11.

Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses.

Sarin R, Wu X, Abraham C.

Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9560-5. doi: 10.1073/pnas.1017854108.

12.

Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development.

Gatzka M, Newton RH, Walsh CM.

J Immunol. 2009 Jul 1;183(1):285-97. doi: 10.4049/jimmunol.0803530.

13.

Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury.

Cairns B, Maile R, Barnes CM, Frelinger JA, Meyer AA.

J Trauma. 2006 Aug;61(2):293-8; discussion 298-9.

PMID:
16917441
14.

Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.

Wolfkamp SC, Verstege MI, Vogels EW, Meisner S, Verseijden C, Stokkers PC, te Velde AA.

Eur J Gastroenterol Hepatol. 2012 Aug;24(8):965-70. doi: 10.1097/MEG.0b013e328354f3d5.

PMID:
22664939
15.

Association between Toll-like receptor 4 and inflammatory bowel disease.

Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL.

Inflamm Bowel Dis. 2005 Jun;11(6):567-75.

PMID:
15905704
16.

Breed-independent toll-like receptor 5 polymorphisms show association with canine inflammatory bowel disease.

Kathrani A, House A, Catchpole B, Murphy A, Werling D, Allenspach K.

Tissue Antigens. 2011 Aug;78(2):94-101. doi: 10.1111/j.1399-0039.2011.01707.x.

PMID:
21623734
17.

CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases.

Wittig B, Seiter S, Schmidt DS, Zuber M, Neurath M, Zöller M.

Lab Invest. 1999 Jun;79(6):747-59.

PMID:
10378517
18.

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kühn R, Müller W, Berg DJ, Rennick DM.

J Exp Med. 1996 Jul 1;184(1):241-51.

19.
20.

Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Rigoli L, Romano C, Caruso RA, Lo Presti MA, Di Bella C, Procopio V, Lo Giudice G, Amorini M, Costantino G, Sergi MD, Cuppari C, Calabro GE, Gallizzi R, Salpietro CD, Fries W.

World J Gastroenterol. 2008 Jul 28;14(28):4454-61.

Items per page

Supplemental Content

Support Center